Persebelle is proud to announce its participation in the IMCAS World Congress 2026 -celebrated at Palais des Congrès de Paris (Paris)- one of the most influential global events in the field of medical aesthetics, dermatology, and plastic surgery. This prestigious congress brings together leading physicians, researchers, and industry innovators to explore the latest scientific advances and technologies shaping the future of aesthetic medicine.
As a company dedicated to the development and distribution of advanced aesthetic bioactive solutions, Persebelle will be present at booth T329, where attendees will have the opportunity to discover innovative products designed to meet the highest standards of safety, efficacy, and clinical performance.
IMCAS World Congress 2026: The Global Meeting Point for Medical Aesthetics in Paris
The IMCAS World Congress is internationally recognized as a benchmark event for scientific excellence and cutting-edge innovation in aesthetic medicine. Each year, it gathers thousands of professionals from around the world, offering a comprehensive program that includes live demonstrations, expert panels, workshops, and evidence-based lectures.
IMCAS 2026 will focus on the most relevant developments in dermatology, plastic surgery, regenerative medicine, and technology-driven treatments, including solutions powered by artificial intelligence. For medical professionals, the congress represents an unparalleled opportunity to update clinical knowledge, refine techniques, and engage directly with the pioneers driving progress in the industry.
Why Persebelle Is Attending IMCAS World Congress 2026
Persebelle’s participation in IMCAS World Congress 2026 is driven by a clear objective: to actively contribute to the advancement of medical aesthetics through science-based solutions and professional engagement. Being present at IMCAS allows the company to align its innovation strategy with the real needs of medical professionals and the latest scientific developments.
Commitment to Scientific Excellence and Innovation
Scientific rigor is at the core of Persebelle’s philosophy. The company continuously invests in research and development to create medical aesthetic solutions that meet the highest standards of safety, efficacy, and clinical reliability.
By participating in IMCAS World Congress 2026, Persebelle stays closely connected to cutting-edge research, emerging technologies, and evidence-based treatment approaches. This commitment ensures that innovation is guided by science and focused on delivering real clinical value.
Supporting Medical Professionals in Aesthetic Medicine
Persebelle believes that strong partnerships with medical professionals are essential for advancing aesthetic medicine. IMCAS provides the ideal environment to engage directly with practitioners, understand their challenges, and discuss best practices in modern aesthetic treatments.
Through open dialogue and knowledge exchange, Persebelle aims to support physicians not only with high-quality products, but also with expertise, transparency, and long-term collaboration.
Discover Persebelle’s Aesthetic Bioactive Solutions at IMCAS
At IMCAS World Congress 2026, Persebelle will present its medical aesthetic solutions in a professional environment designed to facilitate discovery and discussion. The company’s presence at the congress allows attendees to gain a comprehensive understanding of its product philosophy, quality standards, and clinical approach.
Visiting Persebelle at IMCAS offers professionals the opportunity to explore how innovative medical aesthetic products can support safe, effective, and advanced treatments within daily clinical practice.
Advanced Products for Modern Aesthetic Treatments
Persebelle’s product portfolio is developed to meet the evolving demands of modern aesthetic medicine, where minimally invasive procedures, precision, and predictable results are increasingly important.
Each solution is designed with innovation and usability in mind, enabling practitioners to integrate advanced products seamlessly into their treatment protocols. The focus is on supporting natural-looking results while maintaining high clinical performance.
Quality, Safety, and Clinical Performance
Quality and safety are fundamental pillars of Persebelle’s development process. From formulation and manufacturing to distribution, strict quality controls and international regulatory standards are applied at every stage.
This rigorous approach ensures consistent clinical performance and reinforces trust among medical professionals. At IMCAS 2026, Persebelle will highlight the scientific and quality frameworks that support its medical aesthetic solutions.
BelleNAD+: Bioactive Skin Booster for Advanced Skin Revitalization
Among the aesthetic bioactive solutions presented at IMCAS World Congress 2026, BelleNAD+ stands out as an innovative skin booster designed to support advanced skin revitalization. Formulated with Nicotinamide Adenine Dinucleotide (NAD+), BelleNAD+ is developed to help improve skin quality, vitality, and overall appearance by supporting cellular energy and skin regeneration processes. Its bioactive approach is focused on enhancing skin luminosity, texture, and resilience, making it a valuable solution for aesthetic professionals seeking scientifically grounded treatments aimed at skin rejuvenation and long-term skin health. Quality and safety are fundamental pillars of Persebelle’s development process. From formulation and manufacturing to distribution, strict quality controls and international regulatory standards are applied at every stage.
This rigorous approach ensures consistent clinical performance and reinforces trust among medical professionals. At IMCAS 2026, Persebelle will highlight the scientific and quality frameworks that support its medical aesthetic solutions.
What Medical Professionals Can Discover at Persebelle’s Booth (T329)
Persebelle invites all IMCAS World Congress 2026 attendees to visit booth T329 and connect directly with the team. The booth will serve as a dedicated space for professional interaction, product discovery, and scientific discussion.
Visitors will have the opportunity to explore Persebelle’s solutions in detail, ask questions, and engage in meaningful conversations about innovation, quality, and the future of aesthetic medicine.
Connecting with the Future of Aesthetic Medicine at IMCAS 2026
The medical aesthetics industry continues to evolve rapidly, driven by scientific advancements, technological innovation, and increasing demand for safe and effective treatments. IMCAS World Congress 2026 plays a key role in shaping this evolution by bringing together education, research, and industry expertise.
Persebelle is proud to be part of this global event and to contribute to the future of aesthetic medicine through science-driven solutions and professional collaboration.
Join Persebelle at IMCAS World Congress 2026 and visit us at booth T329 to discover innovation backed by science.
